Press Releases

News Brief

Samsung Biologics to attend 2024 BIO International Convention


Samsung Biologics will be attending the 2024 BIO International Convention in San Diego between June 3-6 this year.

The company plans to share its strategic capacity and portfolio expansion plans. Samsung Biologics’ fifth plant is expected to be operational by April 2025, giving the company a total biomanufacturing capacity of 784,000 liters. The company is also constructing a standalone antibody-drug conjugate (ADC) facility, with the aim of completion by the end of this year.

Samsung Biologics will also showcase its strengths and capabilities in the contract development space. The company recently rebranded its CDO services to highlight the key service elements that the company has to offer with its new slogan – ‘Agile. Flexible. Focused on You.’  

Samsung Biologics will also be meeting with existing and potential clients throughout the event to discuss how the company can support them to achieve development and manufacturing milestones.


Samsung Biologics will be attending the 2024 BIO International Convention in San Diego between June 3-6 this year.

The company plans to share its strategic capacity and portfolio expansion plans. Samsung Biologics’ fifth plant is expected to be operational by April 2025, giving the company a total biomanufacturing capacity of 784,000 liters. The company is also constructing a standalone antibody-drug conjugate (ADC) facility, with the aim of completion by the end of this year.

Samsung Biologics will also showcase its strengths and capabilities in the contract development space. The company recently rebranded its CDO services to highlight the key service elements that the company has to offer with its new slogan – ‘Agile. Flexible. Focused on You.’  

Samsung Biologics will also be meeting with existing and potential clients throughout the event to discuss how the company can support them to achieve development and manufacturing milestones.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION